More About Us

Sepax Bioscience, Inc. was established in 2022 in the USA as an additional entity within the Sepax industrial enterprise which originated with Sepax Technologies in 2002 at Delaware Technology Park.  Sepax has been dedicated to chromatography technology for over 20 years serving more than 5,000 customers worldwide. 

Sepax Bioscience develops and manufactures process chromatography media for the global biopharmaceutical industry. Its portfolio contains chromatography resins based on agarose, polymer, and silica and includes various separation modes such as affinity, ion exchange, reverse phase, hydrophobic interaction, and mixed-mode.

Sepax resins support the entire product lifecycle from pre-IND stages through clinical trials (Phases I, II, and III) to commercial GMP production. 

Sepax Bioscience is committed to delivering high-quality chromatography media to meet the downstream purification needs of the biopharmaceutical industry.